patients with osteoarthritis (7.4 + 0 7%, p<OOO1). HbA, was depressed less in active RA than during remission, which is consistent with diminished red cell production in active RA. These data on HbA1 confirm that shortened red cell survival is common in RA, and point to diminished red cell production in active disease. Determination of HbAI should prove to be of clinical value in the assessment of normoglycaemic patients with RA but is an inadequate index of glucose homoeostasis in diabetics with RA.
The anaemia of rheumatoid arthritis (RA) has been attributed to diminished red cell production and shortening of red blood cell (RBC) survival.`-3 HbA, content of erythrocytes is a function of the rate and duration of glycosylation, which in turn are dependent on the concentration of glucose and the duration of erythrocyte survival. for RA included nonsteroidal anti-inflammatory drugs (NSAID) in all patients, gold in 16, D-penicillamine in 6, and azathioprine in 2. The patients with OA were 5 males and 9 females ages 18-82 (mean 59 years), with a mean midmorning blood glucose of 4 4 ± 0 7 mmoUl. All were receiving NSAID therapy similar to that of the RA patients.
Heparinised blood samples for HbA, determination were stored at 4°C for up to 3 days. HbA, was measured as the proportion of total haemoglobin by chromatographic separation at 22 5°C on a Biorex microcolumn (Isolab Ltd., Akron, Ohio, USA). Statistical significance was assessed by Student's t and x2 tests.
Results
HbA, was significantly lower in patients with RA (5.6 + 0 7 %, mean ± SD) than in patients with OA (7.4 ± 0.7%) and controls (7.3 ± 0 7%, p<0O001).
In active RA, HbA, was depressed less (5 9 + 0-6 %) than in patients in remission (5 1 + 0-6 %, p<0 005).
Thus HbA, was within the normal range (5.9-8 7 %) in 11 of 19 patients with active RA but only 2 of 11 patients with inactive disease (p<004, Fig. 1 ).
Furthermore, HbA, correlated directly with ESR (r=0 5, p<0006, Fig. 2 ) and inversely with haemoglobin concentration (r=0-41, p<0002, Fig. 3 ). There was no correlation with age, sex, or therapy. In particular, HbA, was similar whether or not patients were receiving gold thiomalate therapy (5 7 -+ 0 -6 % and 5 5 + 0-8% respectively). 
